Orthofix Medical (OFIX) Stock Price, News & Analysis

Company Overview

Orthofix Medical Inc. (NASDAQ: OFIX) is a medical device company focused on orthopedic and spine care. Its products are designed to support the treatment of spinal conditions, musculoskeletal disorders, fractures and other orthopedic injuries.

The company offers spinal implants and instrumentation, bone graft substitutes and biologic solutions, and technologies intended to support bone growth and healing. Orthofix also provides products for limb reconstruction and extremity fixation, including systems used in the treatment of complex fractures and deformities.

Orthofix markets its products to hospitals, surgeons and other healthcare providers in the United States and international markets. The company’s current business combines the legacy Orthofix portfolio with products from SeaSpine, following the completion of their merger in 2023.

Key Stats

• Today's Range: $9.68 to $9.95
• 50-Day Range: $8.64 to $10.48
• 52-Week Range: $8.50 to $16.99
• Volume: 335,289 shs
• Average Volume: 425,908 shs
• Market Capitalization: $401.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $14.75
• Consensus Rating: Hold

Orthofix Medical Stock Analysis - MarketRank™

Orthofix Medical scored higher than 51% of companies evaluated by MarketBeat, and ranked 616th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

Orthofix Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Orthofix Medical has a consensus price target of $14.75, representing about 49.7% upside from its current price of $9.85.

Amount of Analyst Coverage

Orthofix Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Orthofix Medical are expected to grow in the coming year, from ($1.29) to ($1.07) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Orthofix Medical is -6.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orthofix Medical is -6.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Orthofix Medical has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.16% of the float of Orthofix Medical has been sold short.

Short Interest Ratio / Days to Cover

Orthofix Medical has a short interest ratio ("days to cover") of 5.49.

Change versus previous month

Short interest in Orthofix Medical has recently decreased by 2.56%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Orthofix Medical does not currently pay a dividend.

Dividend Growth

Orthofix Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: N/A

News Sentiment

Orthofix Medical has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Healthcare companies.

Search Interest

Only 1 people have searched for OFIX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Orthofix Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,891.00 in company stock.

Percentage Held by Insiders

2.70% of the stock of Orthofix Medical is held by insiders.

Percentage Held by Institutions

89.76% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 10/20/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:OFIX
• CIK: 884624
• Web: www.orthofix.com
• Phone: (214) 937-2000
• Fax: 599 9 461 6978
• Employees: 1,605
• Year Founded: 1980

Price Target and Rating

• Average Price Target for Orthofix Medical: $14.75
• High Price Target: $17.00
• Low Price Target: $13.00
• Potential Upside/Downside: +49.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.54)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$92.19 million
• Net Margins: -7.41%
• Pretax Margin: -7.24%
• Return on Equity: -14.05%
• Return on Assets: -7.17%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 2.84
• Quick Ratio: 1.67

Sales & Book Value

• Annual Sales: $822.31 million
• Price / Sales: 0.49
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $11.30 per share
• Price / Book: 0.87

Miscellaneous

• Outstanding Shares: 40,730,000
• Free Float: 39,633,000
• Market Cap: $401.19 million
• Optionable: Optionable
• Beta: 0.62